01

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-27

CYCLOSPORINE

US Patent Number : 8648048

Drug Substance Claim :

Drug Product Claim :

Application Number : 50790

Patent Use Code : U-1483

Patent Use Description : INCREASE TEAR PRODUCTI...

Patent Expiration Date : 2024-08-27

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-27

CYCLOSPORINE

US Patent Number : 8633162

Drug Substance Claim :

Drug Product Claim :

Application Number : 50790

Patent Use Code : U-1479

Patent Use Description : INCREASE TEAR PRODUCTI...

Patent Expiration Date : 2024-08-27

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-27

CYCLOSPORINE

US Patent Number : 9248191

Drug Substance Claim :

Drug Product Claim :

Application Number : 50790

Patent Use Code : U-1479

Patent Use Description : INCREASE TEAR PRODUCTI...

Patent Expiration Date : 2024-08-27

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-27

CYCLOSPORINE

US Patent Number : 8629111

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2024-08-27

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-27

CYCLOSPORINE

US Patent Number : 8685930

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2024-08-27

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-02-25

CYCLOSPORINE

US Patent Number : 8292129

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2031-02-25

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-02-07

CYCLOSPORINE

US Patent Number : 9676525

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2034-02-07

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-05-11

CYCLOSPORINE

US Patent Number : 9669974

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2034-05-11

Product Web Link

Corporate PDF

09

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-04-16

CYCLOSPORINE

US Patent Number : 8561859

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2032-04-16

Product Web Link

Corporate PDF

10

ABBVIE

U.S.A

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-27

CYCLOSPORINE

US Patent Number : 8642556

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Patent Use Description :

Patent Expiration Date : 2024-08-27

Product Web Link

Corporate PDF

Information, Expiry & Status of FDA Orange Book Patents covering Restasis

Restasis

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

23 USDMF

11 CEP/COS

9 JDMF

1 EU WC

12 KDMF

21 NDC API

1 VMF

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

32 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

308 FDF Dossiers

53 FDA Orange Book

159 Europe

23 Canada

48 Australia

7 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik

1 Rochem International Inc

2 SPI Pharma

3 Seqens

9 DKSH

1 Jai Radhe Sales

1 PMC Isochem

2 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

4 ACG Worldwide

7 Actylis

1 Aeon Procare

19 BASF

1 Bioplus Life Sciences

1 Clariant

3 Corel Pharma Chem

2 Finar

7 Gangwal Chemicals

2 Kerry

3 Lonza Capsugel

1 Lubrizol Life Science Health

1 Microlex e.U

3 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Pluviaendo

1 Qualicaps

11 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Solubilizers

28 Topical

20 Parenteral

18 Film Formers & Plasticizers

16 Thickeners and Stabilizers

15 Emulsifying Agents

14 Coating Systems & Additives

CAPSULE;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons